Table 2 from First-in-Human Study of 23ME-00610, an Antagonistic Antibody for Genetically Validated CD200R1 Immune Checkpoint, in Participants with Advanced Solid Malignancies
收藏数据链接：
官方服务：
资源简介：
23ME-00610 treatment exposure and AE summary
创建时间：
2025-01-15
